An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Cited by (412)

Items 401–412 of 412

1. Atherosclerosis resolution: strategies to remodel and resolve plaques.
   E. Halbedl, Edward A. Fisher · 2026 · Current Opinion in Lipidology
2. Fatty acid metabolites concentration in the early phase of myocardial infarction and its relation to left ventricular ejection fraction
   Szymon Olędzki, Arnold Kukowka, Aldona Siennicka, Radosław Kiedrowicz, Małgorzata Zielska, Ewa Stachowska, Dominika Maciejewska · 2026 · Prostaglandins & Other Lipid Mediators
3. Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations
   Lazar Mandinov, Chris A. Learn · 2026 · Reviews in Cardiovascular Medicine
4. Impaired Glycolysis Leads to Defective Efferocytosis and Impaired Plaque Resolution in Tet2 Clonal Hematopoiesis
   Mustafa Yalçınkaya, Cheng-Chieh Hsu, Linke Li, Ranran Wang, David Ngai, Pablo Sánchez Vela, Inés Fernández-Maestre, Malgorzata Olszewska, Wenli Liu, Miao Chen et al. · 2026 · Circulation
5. Integrative multi-omics analysis reveals lipid/metabolite dysregulation and temporal decoupling in disease progression
   Uchenna Alex Anyaegbunam, Vincent ten Cate, Katrin Bauer, Thierry Schmidlin, Ute Distler, Stefan Tenzer, Elisa Araldi, Laura Bîndilă, Philipp Wild, Miguel Angel Andrade-Navarro · 2026 · Scientific Reports
6. Tissue‐Resident Macrophage in Inflammation and Cancer
   Siyuan Huang, Jiangbo Fan, Wenyi Liu, Di Liu, Rui Wang, Yuanyang Wang, Jianhui Sun, Huacai Zhang, Qingli Cai, Zhe Xu et al. · 2026 · MedComm
7. Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities
   Roshanak Fekri Yazdi, Sze Ian Tan, Weifeng Bu, BRIAN BASTO FRANCO, Ashton Juin Kai Ng, Hong Yong Peh, Jianmin Chen · 2026 · Pharmacological Research
8. Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities
   Manikandan Subramanian · 2026 · Current topics in microbiology and immunology
9. Revisiting the genetic support of leukotriene pathway drug targets in atherosclerotic cardiovascular disease
   Tristan St-Laurent, Julien St.-Pierre, Julien Quang Le Van, Marc‐André Legault · 2026 · Frontiers in Genetics
10. Resolving the links between efferocytosis and DNMT3A mutation–driven clonal hematopoiesis in atherosclerosis
    Aarti H. Asnani · 2026 · Journal of Clinical Investigation
11. BindingDB Entry 50014464: Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.
    BindingDB · 2022 · UC San Diego
12. Specialized Pro-resolving Mediators and Mimetics: Bridging Resolution Biology and Therapeutic Development
    Braden Millar, Catherine Godson, Monica de Gaetano · 2026 · Current topics in microbiology and immunology